Loading organizations...

This VC firm invests in consumer, enterprise, and healthcare startups globally, with a focus on early-stage, growth-stage, and health-tech investments throug...
Pitango Venture Capital is a $2B venture capital firm with 3 dedicated teams focused on Early Stage (Pitango First), Health-tech (Pitango Health-tech), and Growth (Pitango Growth) investments in consumer, enterprise, and healthcare startups around the world. With offices in Israel and Silicon Valley, Pitango currently manages several venture fundstotaling over $2.4 Billion in committed capital. It has invested in more than 150 companies.
Key people at Pitango Venture Capital.
Pitango Venture Capital was founded in 1993 by Aharon Dovrat (Founder, Board Member Emeritus).
Pitango Venture Capital was founded in 1993 by Aharon Dovrat (Founder, Board Member Emeritus).
Pitango Venture Capital is a leading Israeli-based venture capital firm that invests globally in consumer, enterprise, and healthcare startups, with a strong focus on early-stage, growth-stage, and health-tech sectors. Its mission centers on partnering with visionary entrepreneurs to build groundbreaking companies that generate both financial returns and positive societal impact. Pitango operates through three dedicated funds—Pitango First (seed and early-stage), Pitango Growth, and Pitango HealthTech—supporting over 250 portfolio companies across diverse verticals such as software, internet, mobile, enterprise, consumer, and health technology. The firm is recognized for its strategic guidance, mentorship, and extensive network, helping startups scale and succeed internationally[1][2].
Founded in 1993 by Aharon Dovrat, Chemi Peres, Habib Hazzan, and Rami Kalish, Pitango has evolved into one of Israel’s most active and successful venture capital firms. The founding partners brought together deep industry expertise and a vision to foster innovation in Israel’s burgeoning tech ecosystem. Over the years, Pitango expanded its focus from primarily seed and early-stage investments to include growth-stage and specialized health-tech funds, reflecting the firm’s adaptive strategy to market trends and technological advancements. Key managing partners today include Aaron Mankovski, Ayal Itzkovitz, and Rami Kalish, who continue to drive the firm’s growth and impact[1][2][3].
Pitango rides the global trend of digital transformation and innovation across consumer, enterprise, and healthcare sectors. Its timing is advantageous given the accelerating adoption of health-tech solutions, cloud computing, AI, and mobile technologies worldwide. The firm’s deep roots in Israel’s vibrant tech ecosystem—a recognized global innovation hub—enable it to identify and nurture disruptive startups early. By bridging Israeli innovation with global markets, Pitango influences the broader ecosystem by fostering cross-border collaborations, driving technological advancement, and contributing to the growth of the global startup economy[1][3].
Looking ahead, Pitango is poised to deepen its leadership in health-tech and growth-stage investments, capitalizing on increasing demand for digital health solutions and enterprise software. Trends such as AI integration, personalized medicine, and remote healthcare will likely shape its portfolio focus. The firm’s sustained commitment to impact investing and sustainability may also grow in prominence, aligning financial success with societal benefits. As Pitango continues to expand its global footprint and leverage its extensive network, it is expected to remain a pivotal player in shaping the future of technology innovation and venture capital[1][2].
Key people at Pitango Venture Capital.